Universe Pharmaceuticals (UPC) Inventory Average (2021 - 2026)

Universe Pharmaceuticals has disclosed Inventory Average across 6 years of filings, most recently posting $2086.5 billion for Q1 2026.

• In Q1 2026, Inventory Average fell 21.31% year-over-year to $2086.5 billion; the TTM figure through Mar 2026 stood at $2086.5 billion (down 21.31% YoY), while the FY2025 annual figure was $1965.1 billion, down 22.64% from the prior year.
• Inventory Average came in at $2086.5 billion for Q1 2026 at Universe Pharmaceuticals, down from $2879.6 billion in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $3364.7 billion in Q1 2024 to a low of $2.9 million in Q1 2022.
• Average Inventory Average over 5 years is $1935.8 billion, with a median of $2086.5 billion recorded in 2026.
• Year-over-year, Inventory Average surged 37727921.11% in 2023 and slipped 21.31% in 2026.
• Over 5 years, Inventory Average stood at $1103.2 billion in 2022, then surged by 51.52% to $1671.6 billion in 2023, then surged by 53.24% to $2561.6 billion in 2024, then advanced by 12.41% to $2879.6 billion in 2025, then slipped by 27.54% to $2086.5 billion in 2026.
• Per Business Quant data, the three most recent Inventory Average figures were $2086.5 billion in Q1 2026, $2879.6 billion in Q3 2025, and $2651.5 billion in Q1 2025.